Cachexia Supportive Care Protocol
Primary Stack
Core supplements with strongest evidenceEPA reduces inflammatory cytokines driving muscle wasting; most studied intervention for cancer cachexia; may preserve lean mass
Essential for maintaining muscle mass; leucine-rich protein stimulates muscle protein synthesis
Supporting Studies (1)
Supporting Stack
Additional supplements for enhanced resultsLeucine metabolite; reduces muscle protein breakdown; studied for preserving lean mass in wasting conditions
Supporting Studies (1)
Supports muscle function; deficiency common in cachexia and worsens muscle weakness
Supporting Studies (1)
Supports energy metabolism; may reduce fatigue and improve quality of life in cachexia
Supporting Studies (1)
May help preserve muscle mass and strength; enhances effects of resistance exercise
Supporting Studies (1)
Supports appetite and taste; deficiency common in cachexia; may improve food intake
Supporting Studies (1)
May help with nausea and appetite; anti-inflammatory properties
Supporting Studies (1)
Energy-dense liquid supplements increase caloric intake when eating is difficult
Supporting Studies (1)
How This Protocol Works
Simple Explanation
Cachexia is a complex metabolic syndrome characterized by severe, unintentional weight loss, muscle wasting (sarcopenia), and weakness. It's most commonly associated with cancer but also occurs with heart failure, COPD, kidney disease, and other chronic conditions. Unlike simple starvation, cachexia involves inflammatory processes that drive muscle breakdown even when nutrition is adequate.
CRITICAL: Cachexia requires medical management by a multidisciplinary team. Nutritional support alone cannot fully reverse cachexia because of the underlying metabolic changes.
MEDICAL TREATMENTS may include:
* Omega-3 Fatty Acids (especially EPA) are the most studied supplements for cachexia. EPA reduces inflammatory cytokines (like IL-6, TNF-alpha) that drive muscle wasting. Multiple studies show benefit in preserving lean mass.
* Protein supplementation is essential. High-protein, leucine-rich nutrition supports muscle protein synthesis. Aim for 1.5-2.0g/kg body weight daily.
* HMB (Beta-Hydroxy Beta-Methylbutyrate) is a leucine metabolite that reduces muscle protein breakdown. Studies show it helps preserve lean mass.
* L-Carnitine may help with the fatigue that accompanies cachexia.
* Oral nutritional supplements (like Ensure, Boost, or specialized cancer formulas) add calories and protein when eating regular food is difficult.
Expected timeline: Cachexia is difficult to reverse. Goals are often to stabilize weight, preserve function, and improve quality of life rather than complete reversal.
Clinical Perspective
Cachexia: Complex metabolic syndrome with weight loss, muscle wasting, and weakness. Diagnostic criteria: >5% weight loss in 12 months (or BMI <20) + 3 of: decreased muscle strength, fatigue, anorexia, low fat-free mass index, abnormal biochemistry (elevated CRP, anemia, low albumin). Distinct from starvation - inflammatory-driven; not fully reversible with nutrition alone. Prevalence: affects 50-80% of cancer patients; also seen in heart failure, COPD, CKD, HIV, sepsis. Impact: reduced quality of life, treatment tolerance, and survival.
CRITICAL: Multimodal approach required. Address: underlying disease, nutrition (high calorie, high protein), exercise (resistance training), pharmacological (appetite stimulants, anti-inflammatory), psychological (depression affects intake). Nutrition alone is insufficient - metabolic changes must be addressed. Supplements are part of comprehensive nutritional care.
* Omega-3 Fatty Acids (A-grade): EPA reduces inflammation; preserves lean mass. Cochrane review: (PMID: 27840029). Meta-analysis: (PMID: 28476020). 2-4g EPA+DHA daily. Best evidence for cancer cachexia.
* Protein (A-grade): Muscle preservation. Guidelines: (PMID: 29025082). 1.5-2.0g/kg daily. High-leucine (whey, EAAs).
* HMB (B-grade): Reduces protein breakdown. Meta-analysis: (PMID: 28133901). 3g daily.
* Vitamin D (B-grade): Muscle function; common deficiency. Systematic review: (PMID: 28122805). 2000-4000 IU daily.
* L-Carnitine (B-grade): Energy; fatigue. Meta-analysis: (PMID: 24482002). 2-4g daily.
* Creatine (C-grade): Muscle preservation. Review: (PMID: 27752793). 3-5g daily.
* Zinc (C-grade): Appetite; taste. Review: (PMID: 24580542). 15-30mg daily.
* Ginger (C-grade): Nausea; appetite. Review: (PMID: 23612703). 1-2g daily.
* ONS (A-grade): Calorie/protein supplementation. Guidelines: (PMID: 29025082). 400-600 kcal daily.
Assessment targets: Weight, muscle mass (DEXA, BIA, or CT if available), grip strength, 6-minute walk, inflammatory markers (CRP, albumin), food intake (24-hour recall), quality of life.
Protocol notes: Early intervention: pre-cachexia is more responsive to treatment than refractory cachexia. Exercise: even modest resistance exercise helps preserve muscle; consider physical therapy referral. Appetite stimulants: megestrol acetate (fluid retention, thrombosis risk), corticosteroids (short-term only), cannabinoids (dronabinol). Anamorelin: growth hormone secretagogue approved in Japan/Europe for cancer cachexia - increases lean mass. Enteral/parenteral nutrition: if oral intake insufficient; does not fully reverse cachexia but supports nutrition. Small frequent meals: better tolerated than large meals. Protein distribution: 20-30g protein per meal to maximize synthesis. Timing: protein within 2 hours of exercise if exercising. Specialized formulas: some ONS designed for cachexia with omega-3, HMB added. Nausea management: optimize antiemetics; treat oral problems. Depression/anxiety: affects intake; treat. Family education: realistic expectations; avoid force-feeding which causes distress.